For the year ending 2025-12-31, YBGJ made $12,353 in revenue. -$1,079,248 in net income. Net profit margin of -8736.73%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Sales of products and services | 12,353 | 3,470 | ||
| Cost of goods and services sold | 4,188 | 822 | ||
| Gross profit | 8,165 | 2,648 | ||
| Other operating expenses | - | 341,765 | ||
| Employee compensation | 766,888 | 857,355 | ||
| Occupancy | 116,034 | 390,150 | ||
| Depreciation and amortization of property and equipment | 167,581 | 169,875 | ||
| Amortization of intangible assets | 10,192 | 13,422 | ||
| Other operating expenses | 135,166 | - | ||
| Total operating expenses | 1,195,861 | 1,772,567 | ||
| Loss from operations | -1,187,696 | -1,769,919 | ||
| Loss on obsolescence inventory | 0 | -211,923 | ||
| Interest income (expense) | -243 | 50 | ||
| Total other income (expenses) | -243 | -211,873 | ||
| Loss before provision for income tax | -1,187,939 | -1,981,792 | ||
| Provision for income tax | 0 | - | ||
| Net loss | -1,187,939 | -1,981,792 | ||
| Net loss attributable to non-controlling interest | -108,691 | -206,489 | ||
| Net loss attributable to common stockholders | -1,079,248 | -1,775,303 | ||
| Diluted EPS | -0.01 | -0.02 | ||
| Diluted Average Shares | 139,644,900 | 119,820,790 | ||
Yubo International Biotech Ltd (YBGJ)
Yubo International Biotech Ltd (YBGJ)